BIOPHARMA CREDIT PLC


BioPharma Credit Plc is a closed-ended investment company. The Company’s investment objective is to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company may acquire debt assets from a company operating in the life sciences industry or an entity other than a life sciences company, which directly or indirectly holds an interest in royalty rights to certain products, including any investment vehicle or special purpose vehicle. The Company’s un-invested capital may be invested in cash instruments or bank deposits for cash management purposes. The Company may, from time to time, enter into such hedging or other derivative arrangements. The Company’s investment manager is Pharmakon Advisors L.P.
Bank NameBIOPHARMA CREDIT PLC
Stock ExchangeLSE
SymbolBPCRL
SectorFinancials
IndustryFinancial Services
CountryUnited Kingdom
World RegionEurope
Chairman
CEO
Employees
Website
Registered Year2016

  2017 2016 2015
  € m € m € m
Revenue      
Total interest income
Total Interest Expenses
Net Interest income
Total Net Revenue
       
Earnings per share      
Basic
Diluted
       
Assets      
Total current assets 3,55,860
Other assets
Total assets 9,25,490
Total current liabilities 2,916
Total liabilities 2,916
Total Equity 9,22,574
       
Net income      
Net cash provided by operating activities
Net cash used for investment activities
Net cash provided by financing activities
       
       
Source:http://www.bpcruk.com      
Currency in EUR, All numbers in million.      

04 May 2018 – Holding(s) in Company
02 May 2018 – Holding(s) in Company
01 May 2018 – Update on New Investment
01 May 2018 – Total Voting Rights
26 Apr 2018 – Director Declaration

India
Hyderabad
Patancheru

.